de la Rosa A, Mikhak B, Steeg P S
Women's Cancers Section, Laboratory of Pathology, National Cancer Institute, Bethesda, Maryland, USA.
Arch Med Res. 1996 Autumn;27(3):395-401.
The nm23-H1 gene, localized to chromosome 17q21-22, has been demonstrated in transfection experiments to significantly inhibit the metastatic potential of melanoma and breast carcinoma cell lines. In this study, we report the isolation, sequencing and partial characterization of the nm23-H1 promoter. The nm23-H1 promoter has no TATA box, but it contains a number of sequences which may bind known transcriptional regulatory proteins (AP-1, CTF/NF1, ACAAAG, and Ets). We have also identified two nonconsensus transcriptional start sites within one of the Ets binding sites. Nuclear proteins from HeLa cells bound specifically to a 95 bp region of the nm23-H1 promoter which harbors the CTF/NF1 recognition consensus sequence, suggesting that CTF/NF1 may play a role in nm23-H1 expression.
定位于17q21 - 22染色体的nm23 - H1基因,在转染实验中已被证明能显著抑制黑色素瘤和乳腺癌细胞系的转移潜能。在本研究中,我们报告了nm23 - H1启动子的分离、测序及部分特征。nm23 - H1启动子没有TATA盒,但它包含一些可能结合已知转录调节蛋白(AP - 1、CTF/NF1、ACAAAG和Ets)的序列。我们还在其中一个Ets结合位点内确定了两个非共有转录起始位点。来自HeLa细胞的核蛋白特异性结合到nm23 - H1启动子的一个95 bp区域,该区域含有CTF/NF1识别共有序列,提示CTF/NF1可能在nm23 - H1表达中起作用。